The Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is designed to give investors specific exposure to the worldwide pharmaceutical and biotechnology sectors. These are recognized as some of the most rapidly evolving and research-intensive fields within healthcare. The ETF's objective is to emulate the returns of the BITA Global Pharma and Biotech Select Index, which tracks businesses operating in developed markets that generate a significant portion of their earnings from the invention, progression, and sale of treatments for human health.

Johnson & Johnson

AbbVie Inc.

Merck & Co., Inc.

Novartis AG

Amgen Inc.

Gilead Sciences, Inc.

Vertex Pharmaceuticals Incorporated

Bristol-Myers Squibb Company

Regeneron Pharmaceuticals, Inc.

argenx SE

Portfolio Building Block World Pharma and Biotech Index ETF

PBPH Holdings & Sector Breakdown